5 takeaways from ViVE 2022: Day 1
Healthcare executives and investors shared insights on a wide range of topics from partnering with startups, real world evidence, health equity and new developments in the regulation of patient data.
Healthcare executives and investors shared insights on a wide range of topics from partnering with startups, real world evidence, health equity and new developments in the regulation of patient data.
The timelines for biotech investment is getting shaken up, as new funding models enter the fray. These infographs lay out the change quite nicely.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.